Genomma Lab Internacional SAB de CV
BMV:LABB
Balance Sheet
Balance Sheet Decomposition
Genomma Lab Internacional SAB de CV
Genomma Lab Internacional SAB de CV
Balance Sheet
Genomma Lab Internacional SAB de CV
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
338
|
398
|
645
|
885
|
1 759
|
1 164
|
1 726
|
1 846
|
1 093
|
1 415
|
900
|
2 049
|
1 221
|
1 497
|
1 472
|
2 276
|
|
| Cash |
0
|
0
|
0
|
0
|
338
|
398
|
645
|
670
|
1 279
|
1 094
|
1 570
|
1 821
|
1 045
|
1 369
|
879
|
1 956
|
1 143
|
1 210
|
1 097
|
1 169
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
215
|
480
|
70
|
156
|
26
|
48
|
45
|
21
|
93
|
78
|
287
|
375
|
1 107
|
|
| Short-Term Investments |
82
|
46
|
62
|
1 315
|
740
|
1 057
|
894
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
251
|
484
|
597
|
767
|
1 546
|
2 162
|
3 655
|
5 267
|
5 694
|
5 471
|
3 920
|
4 362
|
5 006
|
5 319
|
6 305
|
7 311
|
7 400
|
6 764
|
6 240
|
6 639
|
|
| Accounts Receivables |
251
|
484
|
597
|
874
|
1 272
|
1 937
|
3 603
|
4 796
|
5 016
|
4 164
|
2 073
|
2 494
|
2 745
|
2 923
|
3 440
|
4 027
|
4 233
|
4 271
|
3 709
|
4 444
|
|
| Other Receivables |
0
|
0
|
0
|
107
|
274
|
225
|
52
|
471
|
678
|
1 307
|
1 847
|
1 868
|
2 260
|
2 396
|
2 866
|
3 283
|
3 167
|
2 494
|
2 531
|
2 195
|
|
| Inventory |
67
|
151
|
228
|
408
|
630
|
947
|
1 101
|
1 032
|
1 442
|
1 595
|
1 159
|
1 172
|
1 264
|
1 697
|
1 908
|
2 046
|
2 202
|
2 397
|
1 911
|
2 176
|
|
| Other Current Assets |
31
|
15
|
29
|
127
|
116
|
121
|
334
|
1 032
|
1 093
|
0
|
735
|
416
|
478
|
567
|
705
|
632
|
698
|
654
|
1 014
|
976
|
|
| Total Current Assets |
431
|
696
|
916
|
2 617
|
3 370
|
4 684
|
6 629
|
8 216
|
9 987
|
17 138
|
7 539
|
7 796
|
7 841
|
8 998
|
9 818
|
12 037
|
11 521
|
11 312
|
10 637
|
12 067
|
|
| PP&E Net |
25
|
25
|
46
|
112
|
261
|
425
|
428
|
404
|
408
|
458
|
407
|
369
|
549
|
1 870
|
2 221
|
2 852
|
3 366
|
3 593
|
3 415
|
3 559
|
|
| PP&E Gross |
25
|
25
|
46
|
112
|
261
|
425
|
428
|
404
|
408
|
458
|
0
|
0
|
549
|
0
|
2 221
|
2 852
|
3 366
|
3 593
|
3 415
|
3 559
|
|
| Accumulated Depreciation |
45
|
43
|
45
|
49
|
79
|
134
|
168
|
228
|
268
|
0
|
0
|
0
|
559
|
0
|
566
|
649
|
772
|
934
|
988
|
1 233
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
48
|
4 340
|
6 861
|
7 063
|
6 469
|
5 260
|
5 181
|
4 936
|
4 913
|
4 908
|
5 169
|
5 151
|
4 954
|
5 927
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
45
|
0
|
52
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
1
|
79
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
81
|
0
|
0
|
5
|
6
|
6
|
18
|
18
|
1 352
|
1 420
|
1 473
|
1 556
|
910
|
909
|
765
|
788
|
729
|
0
|
|
| Other Long-Term Assets |
20
|
12
|
72
|
110
|
611
|
717
|
2 083
|
28
|
78
|
729
|
1 821
|
818
|
843
|
665
|
669
|
634
|
722
|
763
|
963
|
1 466
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
45
|
0
|
52
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
476
N/A
|
735
+54%
|
1 194
+62%
|
2 840
+138%
|
4 242
+49%
|
5 831
+37%
|
9 194
+58%
|
12 993
+41%
|
17 353
+34%
|
25 428
+47%
|
17 633
-31%
|
15 709
-11%
|
15 886
+1%
|
18 077
+14%
|
18 530
+3%
|
21 341
+15%
|
21 543
+1%
|
21 607
+0%
|
20 697
-4%
|
23 018
+11%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
161
|
114
|
79
|
377
|
594
|
969
|
1 262
|
1 219
|
1 644
|
1 555
|
670
|
1 034
|
1 098
|
1 774
|
1 881
|
1 645
|
1 440
|
1 790
|
1 839
|
1 735
|
|
| Accrued Liabilities |
92
|
100
|
151
|
2
|
3
|
12
|
21
|
3
|
10
|
180
|
27
|
3
|
15
|
7
|
38
|
28
|
29
|
41
|
1 062
|
1 610
|
|
| Short-Term Debt |
44
|
111
|
257
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
407
|
805
|
401
|
351
|
2 074
|
3 013
|
676
|
1 569
|
2 007
|
2 105
|
4 851
|
2 005
|
1 375
|
|
| Other Current Liabilities |
1
|
41
|
92
|
144
|
432
|
567
|
903
|
1 002
|
695
|
5 460
|
1 448
|
1 990
|
2 179
|
2 028
|
2 190
|
2 934
|
2 997
|
2 674
|
1 733
|
1 819
|
|
| Total Current Liabilities |
298
|
367
|
579
|
523
|
1 029
|
1 548
|
2 186
|
2 630
|
3 154
|
7 596
|
2 496
|
5 100
|
6 305
|
4 485
|
5 679
|
6 614
|
6 571
|
9 356
|
6 639
|
6 538
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
970
|
3 052
|
4 651
|
6 505
|
5 829
|
3 760
|
1 690
|
5 197
|
4 531
|
4 475
|
3 856
|
1 590
|
4 234
|
5 113
|
|
| Deferred Income Tax |
10
|
17
|
20
|
0
|
46
|
67
|
180
|
229
|
660
|
757
|
2
|
2
|
2
|
100
|
215
|
552
|
555
|
393
|
326
|
380
|
|
| Minority Interest |
2
|
0
|
3
|
1
|
9
|
27
|
42
|
56
|
124
|
124
|
261
|
212
|
202
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
5
|
7
|
5
|
116
|
104
|
286
|
62
|
52
|
67
|
58
|
53
|
840
|
866
|
856
|
858
|
489
|
115
|
114
|
102
|
|
| Total Liabilities |
309
N/A
|
389
+26%
|
609
+57%
|
529
-13%
|
1 200
+127%
|
1 746
+46%
|
3 663
+110%
|
6 029
+65%
|
8 642
+43%
|
15 136
+75%
|
8 645
-43%
|
9 128
+6%
|
9 039
-1%
|
10 649
+18%
|
11 281
+6%
|
12 498
+11%
|
11 471
-8%
|
11 454
0%
|
11 314
-1%
|
12 133
+7%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
266
|
266
|
266
|
275
|
275
|
1 931
|
1 931
|
1 922
|
1 914
|
1 914
|
1 914
|
1 914
|
1 914
|
1 914
|
1 913
|
1 913
|
1 913
|
1 913
|
1 862
|
1 825
|
|
| Retained Earnings |
27
|
154
|
396
|
478
|
1 212
|
2 160
|
3 534
|
5 157
|
6 819
|
8 264
|
7 613
|
5 514
|
5 993
|
6 806
|
6 759
|
8 087
|
9 419
|
10 046
|
10 767
|
11 512
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1 554
|
1 554
|
0
|
0
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
40
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
160
|
75
|
74
|
579
|
1 656
|
1 660
|
1 430
|
1 513
|
1 143
|
1 166
|
1 701
|
1 793
|
1 741
|
|
| Other Equity |
73
|
74
|
78
|
4
|
1
|
7
|
66
|
5
|
13
|
13
|
0
|
769
|
559
|
98
|
50
|
54
|
136
|
148
|
1 495
|
753
|
|
| Total Equity |
167
N/A
|
346
+107%
|
585
+69%
|
2 311
+295%
|
3 042
+32%
|
4 085
+34%
|
5 531
+35%
|
6 963
+26%
|
8 711
+25%
|
10 293
+18%
|
8 988
-13%
|
6 581
-27%
|
6 847
+4%
|
7 428
+8%
|
7 249
-2%
|
8 842
+22%
|
10 072
+14%
|
10 153
+1%
|
9 383
-8%
|
10 885
+16%
|
|
| Total Liabilities & Equity |
476
N/A
|
735
+54%
|
1 194
+62%
|
2 840
+138%
|
4 242
+49%
|
5 831
+37%
|
9 194
+58%
|
12 993
+41%
|
17 353
+34%
|
25 428
+47%
|
17 633
-31%
|
15 709
-11%
|
15 886
+1%
|
18 077
+14%
|
18 530
+3%
|
21 341
+15%
|
21 543
+1%
|
21 607
+0%
|
20 697
-4%
|
23 018
+11%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
843
|
843
|
843
|
1 058
|
1 053
|
1 053
|
1 053
|
1 053
|
1 049
|
1 049
|
1 049
|
1 049
|
947
|
1 018
|
1 013
|
1 011
|
1 003
|
965
|
948
|
978
|
|